{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:42:06Z","timestamp":1782981726346,"version":"3.54.5"},"reference-count":10,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":100,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,8]]},"DOI":"10.1093\/asjof\/ojaf022","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T05:56:46Z","timestamp":1744351006000},"source":"Crossref","is-referenced-by-count":4,"title":["Glucagon-Like Peptide-1 Receptor Agonists: Friend or Foe of Aesthetic Medicine?"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0336-4884","authenticated-orcid":false,"given":"Ashton J","family":"Rosenbloom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P","family":"Gasbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana S","family":"Mamoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5705-8073","authenticated-orcid":false,"given":"Alan D","family":"Widgerow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"2025050905513468000_ojaf022-B1","doi-asserted-by":"publisher","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes\u2014state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"key":"2025050905513468000_ojaf022-B2","doi-asserted-by":"publisher","first-page":"q1645","DOI":"10.1136\/bmj.q1645","article-title":"GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment","volume":"386","author":"Mahase","year":"2024","journal-title":"BMJ"},{"key":"2025050905513468000_ojaf022-B3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/cells13010065","article-title":"GLP1 receptor agonists-effects beyond obesity and diabetes","volume":"13","author":"Wilbon","year":"2023","journal-title":"Cells"},{"key":"2025050905513468000_ojaf022-B4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1055\/a-2148-6321","article-title":"Implications of ozempic and other semaglutide medications for facial plastic surgeons","volume":"39","author":"Humphrey","year":"2023","journal-title":"Facial Plast Surg"},{"key":"2025050905513468000_ojaf022-B5","doi-asserted-by":"publisher","first-page":"NP809","DOI":"10.1093\/asj\/sjae132","article-title":"Decoding the implications of glucagon-like peptide-1 receptor agonists on accelerated facial and skin aging","volume":"44","author":"Ridha","year":"2024","journal-title":"Aesthet Surg J"},{"key":"2025050905513468000_ojaf022-B6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/jcp.30552","article-title":"Insight into the role of dermal white adipose tissue loss in dermal fibrosis","volume":"237","author":"Liu","year":"2022","journal-title":"J Cell Physiol"},{"key":"2025050905513468000_ojaf022-B7","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1111\/dom.15721","article-title":"Incretin-based therapy and the risk of diabetic foot ulcers and related events","volume":"26","author":"Werkman","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2025050905513468000_ojaf022-B8","doi-asserted-by":"publisher","first-page":"113236","DOI":"10.1016\/j.biopha.2022.113236","article-title":"Application of glucagon-like peptide-1 receptor antagonists in fibrotic diseases","volume":"152","author":"Yang","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"2025050905513468000_ojaf022-B9","first-page":"34","article-title":"The use of GLP-1 agonists in the management of cutaneous disease","volume":"17","author":"Lal","year":"2024","journal-title":"J Clin Aesthet Dermatol"},{"key":"2025050905513468000_ojaf022-B10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2337\/db17-0934","article-title":"DPP-4 inhibitors improve diabetic wound healing via direct and indirect promotion of epithelial-mesenchymal transition and reduction of scarring","volume":"67","author":"Long","year":"2018","journal-title":"Diabetes"}],"container-title":["Aesthetic Surgery Journal Open Forum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/asjopenforum\/advance-article-pdf\/doi\/10.1093\/asjof\/ojaf022\/62908754\/ojaf022.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article-pdf\/doi\/10.1093\/asjof\/ojaf022\/62908754\/ojaf022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article-pdf\/doi\/10.1093\/asjof\/ojaf022\/62908754\/ojaf022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T09:51:51Z","timestamp":1746784311000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asjopenforum\/article\/doi\/10.1093\/asjof\/ojaf022\/8110799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":10,"URL":"https:\/\/doi.org\/10.1093\/asjof\/ojaf022","relation":{},"ISSN":["2631-4797"],"issn-type":[{"value":"2631-4797","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"ojaf022"}}